News – Page 105 – Endpoints News

Sanofi's BTK inhibitor again slows MS progression, but liver enzymes continue to be tricky

8 months ago

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

8 months ago

House committee advances PRV reauthorization, but timing on final passage remains 'murky'

8 months ago

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

8 months ago

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

8 months ago

BioCentriq names ex-Resilient exec as new CEO; Sanofi, AstraZeneca boost Beyfortus production

8 months ago

Fertility benefits giant Progyny loses client that accounted for 13% of its revenue

8 months ago

Edgewise’s stock surges as heart drug passes early safety test

8 months ago

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

8 months ago

4DMT's gene therapy reduced need for standard-of-care injections to treat age-associated vision loss

8 months ago

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

8 months ago

Sheryl Sandberg-backed Cercle raises $6M seed round with future plans to sell its services to pharma

8 months ago

FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions

8 months ago

Stem cell startup spun out of George Church’s lab raises $75M

8 months ago

Tang Capital’s Concentra bids for Singular Genomics days after Deerfield offer

8 months ago

Upstream Bio files for IPO in sign of life for biotech public offerings

8 months ago

FDA approves AstraZeneca’s asthma medication Fasenra to treat rare autoimmune condition

8 months ago

Here's what today's Fed rate cut means for biotech, pharma and venture capital

8 months ago

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

8 months ago

Keytruda adds new FDA approval for a rare form of mesothelioma

8 months ago

Senators tell FDA that ‘greater action is needed’ to use manufacturing tech in US supply chains

8 months ago

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

8 months ago

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

8 months ago

Novo Nordisk signs genetic medicine pact, inking deal with NanoVation

8 months ago

First page Previous page 102 103 104105106 107 108 Next page Last page